The nocebo effect and patient perceptions of biosimilars in inflammatory bowel disease

被引：0
作者：
David Pineles
Lisa Malter
Peter S. Liang
Amy Arsuaga
Brian Bosworth
David P. Hudesman
Shannon Chang
机构：
[1] NYU Langone Health,Department of Medicine
[2] Bellevue Hospital,Division of Gastroenterology
[3] Manhattan Medical Center,Division of Gastroenterology, VA New York Harbor Healthcare System
[4] NYU Langone Health,Inflammatory Bowel Disease Center, Division of Gastroenterology
来源：
European Journal of Clinical Pharmacology | 2018年 / 74卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1361 / 1362
页数：1
相关论文
共 13 条
  • [1] Boone NW(2018)The nocebo effect challenges the non-medical infliximab switch in practice Eur J Clin Pharmacol 74 655-661
  • [2] Liu L(2016)Patient attitudes and understanding about biosimilars: an international cross-sectional survey Patient Prefer Adherence 10 937-948
  • [3] Romberg-camps MJ(2017)Perception of originator biologics and biosimilars: a survey among Belgian rheumatoid arthritis patients and rheumatologists BioDrugs 31 447-459
  • [4] Jacobs I(undefined)undefined undefined undefined undefined-undefined
  • [5] Singh E(undefined)undefined undefined undefined undefined-undefined
  • [6] Sewell KL(undefined)undefined undefined undefined undefined-undefined
  • [7] Al-Sabbagh A(undefined)undefined undefined undefined undefined-undefined
  • [8] Shane LG(undefined)undefined undefined undefined undefined-undefined
  • [9] van Overbeeke E(undefined)undefined undefined undefined undefined-undefined
  • [10] de Beleyr B(undefined)undefined undefined undefined undefined-undefined
12